Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy

被引：0
|
作者：
Gengshen Yin
Liyuan Liu
Ting Yu
Lixiang Yu
Man Feng
Chengjun Zhou
Xiaoying Wang
Guoxin Teng
Zhongbing Ma
Wenzhong Zhou
Chunmiao Ye
Jialin Zhang
Changhua Ji
Linfeng Zhao
Peng Zhou
Yaxun Guo
Xingchen Meng
Qinye Fu
Qiang Zhang
Liang Li
Fei Zhou
Chao Zheng
Yujuan Xiang
Mingming Guo
Yongjiu Wang
Fei Wang
Shuya Huang
Zhigang Yu
机构：
[1] The Second Hospital of Shandong University,Department of Breast Surgery
[2] Shandong University,Institute of Translational Medicine of Breast Disease Prevention and Treatment
[3] Shandong Provincial Engineering Laboratory of Translational Research On Prevention and Treatment of Breast Disease,Research Center for Mathematics and Interdisciplinary Sciences
[4] Shandong University,Department of Pathology
[5] Department of Pathology,Institute of Medical Sciences
[6] The Third Affiliated Hospital of Shandong First Medical University (Affiliated Hospital of Shandong Academy of Medical Sciences),Department of Breast Surgery
[7] The Second Hospital of Shandong University,undefined
[8] The Second Hospital of Shandong University,undefined
[9] Weifang People’s Hospital,undefined
来源：
Genome Medicine | / 16卷
关键词：
Breast cancer; Neoadjuvant chemotherapy; Genomic; Transcriptomic; Pathological response; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy
    Yin, Gengshen
    Liu, Liyuan
    Yu, Ting
    Yu, Lixiang
    Feng, Man
    Zhou, Chengjun
    Wang, Xiaoying
    Teng, Guoxin
    Ma, Zhongbing
    Zhou, Wenzhong
    Ye, Chunmiao
    Zhang, Jialin
    Ji, Changhua
    Zhao, Linfeng
    Zhou, Peng
    Guo, Yaxun
    Meng, Xingchen
    Fu, Qinye
    Zhang, Qiang
    Li, Liang
    Zhou, Fei
    Zheng, Chao
    Xiang, Yujuan
    Guo, Mingming
    Wang, Yongjiu
    Wang, Fei
    Huang, Shuya
    Yu, Zhigang
    [J]. GENOME MEDICINE, 2024, 16 (01)
  • [2] Exosomal metabolic signatures are associated with differential response to neoadjuvant chemotherapy in patients with breast cancer
    Joshi, Shriya
    Garalapati, Chakravarthy
    Bhattarai, Shristi
    Chandrashekar, Darshan Shimoga
    Varambally, Sooryanarayana
    Deep, Gagan
    Aneja, Ritu
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [3] Exosomal Metabolic Signatures Are Associated with Differential Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
    Joshi, Shriya
    Garlapati, Chakravarthy
    Bhattarai, Shristi
    Su, Yixin
    Rios-Colon, Leslimar
    Deep, Gagan
    Torres, Mylin A.
    Aneja, Ritu
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [4] Defining peritumoral and tumoral stromal gene signatures associated with response to neoadjuvant chemotherapy in breast cancer
    Pourreyron, Celine
    Warwick, Violet
    Whelehan, Patsy
    Coates, Philip
    Jordan, Lee
    Purdie, Colin
    Vinnicombe, Sarah
    Thompson, Alastair
    Evans, Andrew
    Fuller-Pace, Frances
    [J]. CANCER RESEARCH, 2017, 77
  • [5] Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
    Ji, Fei
    Yuan, Jiao-Mei
    Gao, Hong-Fei
    Xu, Ai-Qi
    Yang, Zheng
    Yang, Ci-Qiu
    Zhang, Liu-Lu
    Yang, Mei
    Li, Jie-Qing
    Zhu, Teng
    Cheng, Min-Yi
    Wu, Si-Yan
    Wang, Kun
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [6] Assessment of Genomic Prognostic Signatures as Predictors of Response to Neoadjuvant Chemotherapy in Patients with Early Stage Breast Cancer.
    Culakova, E.
    Poniewierski, M. S.
    Huang, M.
    Kuderer, N. M.
    Ginsburg, G. S.
    Barry, W.
    Marcom, P. K.
    Ready, N.
    Abernethy, A.
    Lyman, G. H.
    [J]. CANCER RESEARCH, 2011, 71
  • [7] Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures
    Peter Beitsch
    Pat Whitworth
    Paul Baron
    James Pellicane
    Tina Treece
    Erin Yoder
    Mark Gittleman
    [J]. Annals of Surgical Oncology, 2016, 23 : 3317 - 3323
  • [8] Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures
    Beitsch, Peter
    Whitworth, Pat
    Baron, Paul
    Pellicane, James
    Treece, Tina
    Yoder, Erin
    Gittleman, Mark
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (10) : 3317 - 3323
  • [9] Genomic predictors of neoadjuvant chemotherapy (NACT) response in breast cancer (BC).
    Wong, Andrea Li Ann
    Tan, Kar Tong
    Sundar, Raghav
    Ow, Samuel
    Pang, Angela
    Yap, Hui-Ling
    Chan, Ching-Wan
    Hartman, Mikael
    Iau, Philip
    Buhari, Shaik Ahmad
    Mogro, Maria Jannet
    Tan, Lain BeeHuat
    Wang, Ling-Zhi
    Yang, Henry
    Goh, Boon C.
    Lee, Soo-Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Integrative genomic, transcriptomic and functional genomic analysis identifies novel therapeutic targets for breast cancers
    Reis-Filho, Jorge
    [J]. JOURNAL OF MEDICAL GENETICS, 2009, 46 : S35 - S35
12345